---
title: "Personalis is said to have attracted takeover interest from Merck"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293038787.md"
description: "Personalis shares rose ~4% in premarket trading after reports revealed takeover interest from Merck and two other bidders. The company is exploring a potential sale, having hired Cooley for legal counsel and Centerview and TD Securities as bankers to evaluate offers. Personalis, a cancer test developer with a $1.6B market cap, has seen its stock rally nearly 100% this year despite recording an $81.3M net loss last year."
datetime: "2026-07-17T12:45:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293038787.md)
  - [en](https://longbridge.com/en/news/293038787.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293038787.md)
---

# Personalis is said to have attracted takeover interest from Merck


### Related Stocks

- [PSNL.US](https://longbridge.com/en/quote/PSNL.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Aspen Pharmacare signs voluntary licensing deal with MSD for once-monthly HIV prevention pill MK-8527](https://longbridge.com/en/news/293755123.md)
- [Agilent wins EU approval for PD-L1 IHC 22C3 test in ovarian cancer patients](https://longbridge.com/en/news/293612650.md)
- [YD Bio launches cancer testing pilot with Numia Health in Canada](https://longbridge.com/en/news/294062286.md)
- [09:01 ETFCANCER CELEBRATES LANDMARK 100TH EVENT WITH DILLON FRANCIS, DIPLO & DJ PAULY D, MARKING YEARS OF IMPACT IN CANCER PREVENTION](https://longbridge.com/en/news/294070677.md)
- [Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey | ELV Stock News](https://longbridge.com/en/news/294391678.md)